The Atherogenic Role of Circulating Modified Lipids in Atherosclerosis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Atherogenic Role of Circulating Modified Lipids in Atherosclerosis
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 14, Pages 3561
Publisher
MDPI AG
Online
2019-07-22
DOI
10.3390/ijms20143561
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Modified low-density lipoproteins as biomarkers in diabetes and metabolic syndrome
- (2018) Jose Luis Sanchez-Quesada Frontiers in Bioscience-Landmark
- Diagnostics and Therapy of human diseases - Focus on sialidases
- (2018) V. P. Karagodin et al. CURRENT PHARMACEUTICAL DESIGN
- Coronary atherosclerosis in indigenous South American Tsimane: a cross-sectional cohort study
- (2017) Hillard Kaplan et al. LANCET
- Comparison of the Protective Effects of Individual Components of Particulatedtrans-Sialidase (PTCTS), PTC and TS, against High Cholesterol Diet-Induced Atherosclerosis in Rabbits
- (2017) Shérrira M. Garavelo et al. Biomed Research International
- A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality
- (2016) Rishi K. Wadhera et al. Journal of Clinical Lipidology
- Lipid composition of circulating multiple-modified low density lipoprotein
- (2016) E. R. Zakiev et al. Lipids in Health and Disease
- Cellular models of atherosclerosis and their implication for testing natural substances with anti-atherosclerotic potential
- (2016) Alexander N. Orekhov et al. PHYTOMEDICINE
- Relation Between Adolescent Cardiovascular Risk Factors and Carotid Intima‐Media Echogenicity in Healthy Young Adults: The Atherosclerosis Risk in Young Adults (ARYA) Study
- (2016) Anouk L. M. Eikendal et al. Journal of the American Heart Association
- GW26-e0208 Naturally occurring multiple-modified low density lipoprotein (LDL)
- (2015) Alexander N. Orekhov et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Direct Medical Costs of Hospitalizations for Cardiovascular Diseases in Shanghai, China
- (2015) Shengnan Wang et al. MEDICINE
- Development of Antiatherosclerotic Drugs on the basis of Natural Products Using Cell Model Approach
- (2015) Alexander N. Orekhov et al. Oxidative Medicine and Cellular Longevity
- All Low-Density Lipoprotein Particles Are Not Created Equal
- (2014) Ronald M. Krauss ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Healthy Lifestyle Change and Subclinical Atherosclerosis in Young Adults
- (2014) Bonnie Spring et al. CIRCULATION
- Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3)
- (2014) HEART
- Modified Low Density Lipoprotein and Lipoprotein-Containing Circulating Immune Complexes as Diagnostic and Prognostic Biomarkers of Atherosclerosis and Type 1 Diabetes Macrovascular Disease
- (2014) Alexander Orekhov et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Low Density Lipoprotein-Containing Circulating Immune Complexes: Role in Atherosclerosis and Diagnostic Value
- (2014) Igor A. Sobenin et al. Biomed Research International
- Small dense LDL: An emerging risk factor for cardiovascular disease
- (2012) Satoshi Hirayama et al. CLINICA CHIMICA ACTA
- Small dense LDL is more susceptible to glycation than more buoyant LDL in Type 2 diabetes
- (2012) Nahla N. Younis et al. CLINICAL SCIENCE
- Coronary Heart Disease in Young Adults
- (2012) Jessica B. Rubin et al. Current Atherosclerosis Reports
- Diagnostic and Prognostic Value of Low Density Lipoprotein-Containing Circulating Immune Complexes in Atherosclerosis
- (2012) Igor A. Sobenin et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Hypomorphic sialidase expression decreases serum cholesterol by downregulation of VLDL production in mice
- (2012) Abraham Yang et al. JOURNAL OF LIPID RESEARCH
- LDL Cholesterol: The Lower the Better
- (2012) Seth S. Martin et al. MEDICAL CLINICS OF NORTH AMERICA
- Small dense LDL cholesterol is a robust therapeutic marker of statin treatment in patients with acute coronary syndrome and metabolic syndrome
- (2011) Yoshifumi Fukushima et al. CLINICA CHIMICA ACTA
- Susceptibility of LDL and its subfractions to glycation
- (2011) Handrean Soran et al. CURRENT OPINION IN LIPIDOLOGY
- Small, dense LDL cholesterol and apolipoprotein B: Relationship with serum lipids and LDL size
- (2009) Jelena Vekic et al. ATHEROSCLEROSIS
- Plasma oxidized lipoprotein(a) and its immune complexes are present in newborns and children
- (2009) Junjun Wang et al. CLINICA CHIMICA ACTA
- Relationship of Oxidized Phospholipids and Biomarkers of Oxidized Low-Density Lipoprotein With Cardiovascular Risk Factors, Inflammatory Biomarkers, and Effect of Statin Therapy in Patients With Acute Coronary Syndromes
- (2009) Alexander E. Fraley et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Pathology of Atherosclerosis: Plaque Development and Plaque Responses to Medical Treatment
- (2008) William Insull AMERICAN JOURNAL OF MEDICINE
- Glycation of LDL in non-diabetic people: Small dense LDL is preferentially glycated both in vivo and in vitro
- (2008) Nahla Younis et al. ATHEROSCLEROSIS
- Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome
- (2008) Manfredi Rizzo et al. CLINICAL ENDOCRINOLOGY
- Glycation as an atherogenic modification of LDL
- (2008) Nahla Younis et al. CURRENT OPINION IN LIPIDOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now